Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology · Small Fiber Neuropathy

Diagnosis & Testing: Why Standard Tests Fail

At a Glance

Standard nerve tests like EMGs often appear normal in patients with small fiber neuropathy because they only measure large nerves. The most reliable way to accurately diagnose SFN is through a skin punch biopsy, which directly counts the density of small nerve fibers in the skin.

One of the most frustrating experiences for a patient with Small Fiber Neuropathy (SFN) is being told that their “nerves are fine” after a standard medical test. This often happens because the most common tools used to measure nerves are not designed to see the ones that are causing your pain.

Understanding the specific tests used for SFN allows you to advocate for the right diagnostics and correctly interpret the results.

Why Your EMG/NCS Was “Normal”

If you have had an Electromyography (EMG) or a Nerve Conduction Study (NCS), you may have been told the results were normal despite your symptoms [1].

  • Large Fibers Only: These standard tests are designed to measure large, heavily insulated (myelinated) nerve fibers that control muscles and vibration sense [1].
  • The SFN Blind Spot: Large-fiber tests are physically incapable of “seeing” the small, uninsulated A-delta and C fibers [2].

In fact, a normal EMG/NCS is a key requirement for a “pure” SFN diagnosis, as it proves that your large motor nerves are still healthy [1][3].

The Gold Standard: Skin Punch Biopsy

The most reliable way to diagnose SFN is a skin punch biopsy for Intraepidermal Nerve Fiber Density (IENFD) [4][5].

  • The Procedure: A doctor uses a small 3mm tool (about the size of a pencil eraser) to take a tiny sample of skin, usually from the ankle and the distal thigh [6]. It is a minimally invasive procedure performed with local numbing and typically does not require stitches [5].
  • What They Look For: A pathologist uses specialized staining to count the number of nerve endings in the top layer of your skin [4]. If the density of these fibers is below the expected range for your age, it confirms a diagnosis of SFN [7].

Functional Testing: QST and QSART

While a biopsy shows the structure of the nerves, other tests measure how well they function.

  • Quantitative Sensory Testing (QST): This non-invasive test measures your ability to sense changes in temperature and vibration [8]. It helps doctors understand if your small fibers are over-reacting (hyperexcitability) or under-reacting (loss of sensation) [9].
  • QSART (Quantitative Sudomotor Axon Reflex Test): This test measures your autonomic small fibers by stimulating sweat glands with a mild electrical current and measuring the sweat response [10]. An abnormal result suggests that the nerves controlling your internal body functions are affected [11].

Checklist for a Complete Pathology Report

When you receive your biopsy results, ensure the report is detailed enough to be useful. A complete report should include:

  1. Exact Fiber Count: The number of fibers per millimeter (fibers/mm) for every site tested [7].
  2. Age-Matched Norms: Nerve density naturally decreases as we get older, so your results must be compared against healthy people of your same age [12][7].
  3. Site Comparison (Ankle vs. Thigh): Comparing these two sites helps determine if the disease is length-dependent (worse at the ankle) or non-length-dependent (equally damaged at both sites) [13].
  4. Standardized Laboratory: The sample should be processed by a lab that specializes in IENFD to ensure the most accurate results [14].

Common questions in this guide

Why was my EMG normal if I have small fiber neuropathy?
Standard EMG and nerve conduction studies only measure large, insulated nerve fibers. They are physically incapable of detecting damage to the small, uninsulated nerve fibers that cause small fiber neuropathy symptoms.
What is the best test to diagnose small fiber neuropathy?
The gold standard for diagnosing small fiber neuropathy is a skin punch biopsy. This is a minimally invasive procedure where a small skin sample is taken to measure your intraepidermal nerve fiber density (IENFD).
How is autonomic small fiber neuropathy tested?
Doctors evaluate autonomic small nerve fibers using the Quantitative Sudomotor Axon Reflex Test (QSART). This non-invasive test stimulates your sweat glands with a mild electrical current and measures the sweat response to check your internal nerve function.
What should I look for in my skin biopsy pathology report?
Your report should include the exact fiber count per millimeter, compare your results against healthy people your age, and compare sites like the ankle and thigh to see if your nerve damage is length-dependent.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.My EMG was normal, but we suspect SFN. Can you explain why that is a common finding for my symptoms?
  2. 2.Does my skin biopsy pathology report include age-matched normative values for someone my age?
  3. 3.What was my exact fiber count per millimeter at the ankle vs. the thigh?
  4. 4.Based on the ankle-to-thigh ratio, do my results suggest a 'length-dependent' or 'non-length-dependent' pattern?
  5. 5.If my skin biopsy is negative but my symptoms persist, would you recommend autonomic testing like QSART or a corneal confocal microscopy scan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Small fiber neuropathy: a disabling and underrecognized syndrome.

    Voortman M, Fritz D, Vogels OJM, et al.

    Current opinion in pulmonary medicine 2017; (23(5)):447-457 doi:10.1097/MCP.0000000000000413.

    PMID: 28639956
  2. 2

    Assessment of small fiber neuropathy and distal sensory neuropathy in female patients with fibromyalgia.

    Min HK, Im S, Park GY, Moon SJ

    The Korean journal of internal medicine 2024; (39(6)):989-1000 doi:10.3904/kjim.2024.038.

    PMID: 39468927
  3. 3

    Investigation of small fiber neuropathy in patients with diabetes mellitus by corneal confocal microscopy.

    Kaplan H, Yüzbaşıoğlu S, Vural G, Gümüşyayla Ş

    Neurophysiologie clinique = Clinical neurophysiology 2024; (54(4)):102955 doi:10.1016/j.neucli.2024.102955.

    PMID: 38422588
  4. 4

    Advances in the Management of Small Fiber Neuropathy.

    Zeidman LA

    Neurologic clinics 2021; (39(1)):113-131 doi:10.1016/j.ncl.2020.09.006.

    PMID: 33223078
  5. 5

    Diagnostic and Screening Laboratory Tests in the Assessment of Patients With Small Fiber Neuropathy: An Evidence-Based Review-Report of the American Association of Neuromuscular and Electrodiagnostic Medicine Small Fiber Neuropathy Task Force.

    Katzberg HD, So Y, Brannagan T, et al.

    Muscle & nerve 2026; (73(6)):952-960 doi:10.1002/mus.70119.

    PMID: 41670166
  6. 6

    Non-length-dependent small fiber neuropathy: Not a matter of stockings and gloves.

    Gemignani F, Bellanova MF, Saccani E, Pavesi G

    Muscle & nerve 2022; (65(1)):10-28 doi:10.1002/mus.27379.

    PMID: 34374103
  7. 7

    Reliable Method for Estimating Nerve Fiber Density in Epidermis Using Routine Histopathologic Tissue Preparation: A Promising Diagnostic Tool for Small Fiber Neuropathy.

    Aspegren O, Pourhamidi K

    Applied immunohistochemistry & molecular morphology : AIMM 2024; (32(5)):215-221 doi:10.1097/PAI.0000000000001193.

    PMID: 38650330
  8. 8

    Quantitative sensory testing (QST). English version.

    Mücke M, Cuhls H, Radbruch L, et al.

    Schmerz (Berlin, Germany) 2021; (35(Suppl 3)):153-160 doi:10.1007/s00482-015-0093-2.

    PMID: 26826097
  9. 9

    Quantitative sensory testing in pain management.

    Roldan CJ, Abdi S

    Pain management 2015; (5(6)):483-91 doi:10.2217/pmt.15.37.

    PMID: 26399563
  10. 10

    Pain and small-fiber affection in hereditary neuropathy with liability to pressure palsies (HNPP).

    Dukefoss TT, Kleggetveit IP, Helås T, Jørum E

    Scandinavian journal of pain 2019; (20(1)):61-68 doi:10.1515/sjpain-2019-0090.

    PMID: 31536037
  11. 11

    Which Method for Diagnosing Small Fiber Neuropathy?

    Fabry V, Gerdelat A, Acket B, et al.

    Frontiers in neurology 2020; (11()):342 doi:10.3389/fneur.2020.00342.

    PMID: 32431663
  12. 12

    Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy.

    Collongues N, Samama B, Schmidt-Mutter C, et al.

    PloS one 2018; (13(1)):e0191614 doi:10.1371/journal.pone.0191614.

    PMID: 29370274
  13. 13

    The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy.

    Provitera V, Gibbons CH, Wendelschafer-Crabb G, et al.

    European journal of neurology 2018; (25(6)):848-853 doi:10.1111/ene.13608.

    PMID: 29493845
  14. 14

    Technical aspects and current clinical applications of the skin and skeletal muscle biopsy in neurological diagnostics: an overview.

    Dziewulska D, Kierdaszuk B, Gogol P

    Folia neuropathologica 2022; (60(3)):277-283 doi:10.5114/fn.2022.119980.

    PMID: 36382479

This page explains diagnostic testing for small fiber neuropathy for educational purposes only. Always consult your neurologist or specialist to interpret your specific test results and determine the right diagnostic plan for you.

Get notified when new evidence is published on Idiopathic small fibers neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.